Fulcrum Therapeutics(FULC) - 2025 Q4 - Earnings Call Transcript

Fulcrum Therapeutics (NasdaqGM:FULC) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Speaker10Good morning, and welcome to Fulcrum Therapeutics' conference call to discuss 12-week data from the 20-milligram cohort of the phase 1b PIONEER trial of pociredir and sickle cell disease. Currently, all participants are in a listen-only mode. This call is being webcast live and can be accessed on the Investors section of Fulcrum's website at www.fulcrumtx.com, where a replay will be available. I'll now turn the ...